Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

JAX team to study cancer immunotherapy

The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host genetics on...

| By Kelley Gipson

BioXcel announces Phase 3 agitation studies

BioXcel Therapeutics has announced announced the initiation of its SERENITY (Sub-Lingual DExmedetomidine in Agitation Associated With SchizophRENIa and Bipolar Disorder STudY) program, two Phase 3 studies of...

| By Kelley Gipson

Melinta announces restructuring agreement

Melinta Therapeutics has entered into a restructuring support agreement with the lenders pursuant to a pre-negotiated chapter 11 plan of reorganization. “We are confident that...

| By Kelley Gipson

Alexion exercises RNAi program options

Alexion Pharmaceuticals and Dicerna™ Pharmaceuticals have announced that Alexion has exercised its option for exclusive rights to two additional targets within the complement pathway for...

| By Bill Kelly

Biohaven focuses on alleviating migraine pain

More than one in 10 Americans suffer from migraine headaches, and the vast majority of patients report that the pain prevents them from working. Biohaven...

| By Bill Kelly

NSF grant funds interdisciplinary STEM research

Rebecca Campbell-Montalvo, postdoctoral research associate in the Neag School’s Department of Curriculum and Instruction, is co-principal investigator on a new $500,000 federal research grant funded...

| By Bill Kelly

Achillion shareholders approve Alexion takeover

Shareholders of Achillion Pharmaceuticals have overwhelmingly approved the company’s takeover by fellow New Haven-born drug maker Alexion Pharmaceuticals for $930 million. Achillion said approximately 99...

| By Kelley Gipson

UConn listed among top entrepreneur programs

Almost every course in the UConn entrepreneurship curriculum has moved away from exam-based assessment and theoretical course content, in favor of building and doing. Furthermore,...